Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Clinical approach to lupus nephritis: Recent advances
European Journal of Internal Medicine , 09/02/09
Molino C et al. – Current treatment regimens combine corticosteroids with cyclophosphamide, azathioprine or ciclosporin; mycophenolate mofetil has received much recent attention as a potentially immune suppressive agent and less aggressive immunosuppressive regimens can be prescribed. SLE patients should be regular followed to detect early kidney involvement.
Related Articles
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Relevance Score: 69%
Biomarkers for Lupus Nephritis: The Quest Continues
Clinical Journal of the American Society of Nephrology, 11/13/09
Relevance Score: 68%
Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: a case report and review of the literature
Rheumatology International, 11/13/09
Relevance Score: 67%
Male gender results in more severe lupus nephritis
Rheumatology International, 10/05/09
Relevance Score: 67%
Clinical-Pathological Features and Prognosis of Thrombotic Thrombocytopenic Purpura in Patients With Lupus Nephritis
The American Journal of the Medical Sciences, 11/13/09
Relevance Score: 65%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety of TNF blocking agents in rheumatic patients with serology suggesting past-hepatitis B state: Results from a cohort of 21 patients
Arthritis Research & Therapy, 11/27/09
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/25/09
Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
Peripheral vascular damage in systemic lupus erythematosus: Data from LUMINA, a large multi-ethnic U.S. cohort (LXIX)
Lupus, 11/28/09
Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors
Lupus, 11/27/09
The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus
Lupus, 11/27/09
Sponsor
Article Search
Sponsor


See Latest Articles


